Skip to main content

Table 1 Immunohistochemical staining for HER 2 according to clinical characteristics of patients, stage and histological type of tumor

From: The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients

Patient characteristics

Number of patients

HER 2 +(%)

Total Patients

73

21 (28.8)

Sex

  

Male

69

19 (27.5)

Female

4

2 (50)

Stage

  

Stage IIIB

30

9 (30)

Stage IV

43

12 (27.9)

Histopathology

  

Adenocarcinoma

27

11 (40.7)

Squamous cell (Epidermoid)

34

5 (14.7)

Not otherwise specified (NOS)

12

5 (41.6)